Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
October 28, 2023 9:02 AM 2 min read

Marijuana Legalization: 31 Bipartisan House Reps Urge DEA To Reassess Cannabis Scheduling

by Maureen Meehan Benzinga Editor
Follow

A coalition of 31 bipartisan House members sent a letter to DEA administrator Anne Milgram, urging the agency to consider congressional and state marijuana legalization efforts as it carries out its review into cannabis scheduling, which was recommended by President Biden nearly one year ago when he pardoned 6,500 federal cannabis convictions. 

Rescheduling Is Not Enough

The lawmakers also criticized the limitations of rescheduling and pushed for a complete removal of marijuana from the Controlled Substances Act (CSA). At the end of August, the Department of Health and Human Services (HHS) recommended that the DEA move marijuana from Schedule I to Schedule III of the CSA.

The Friday letter to DEA’s Milgram, led by Congressional Cannabis Caucus co-chairs Rep. Earl Blumenauer (D-OR), Dave Joyce (D-OR), Barbara Lee (D-CA) and Brian Mast (R-FL) and first reported by Punchbowl News, stated that the ongoing marijuana scheduling is a “necessary step in the work to end the federal government’s failed and discriminatory prohibition of cannabis.”

As the agency continues its review, which is expected to be completed at the end of the year, the lawmakers said that the DEA should also consider that Congress has been working for comprehensive reform of cannabis laws, including cannabis banking.

Lawmakers pointed out that practically the entire country has enacted some form of legalization and Democrats, as well as GOP members, have introduced legislation seeking cannabis reform. This week, Rep. Nancy Mace (R-SC) refiled the bipartisan States Reform Act, which seeks to reschedule marijuana on a federal level. It was first introduced in 2021 with at least a half-dozen Republicans as sponsors. 

The House has passed comprehensive legalization twice, the lawmakers noted.

“Additionally, ending the unjust scheduling of marijuana and normalizing federal cannabis regulation go hand-in-hand. The federal government must correct this prohibition and the continued criminalization of otherwise legal marijuana—creating legal job opportunities, promoting public safety not unjust incarceration, and upholding established state regulation of cannabis production, taxation, and sales," says the letter. "We do not negate the need for corresponding legislative action on many of these components, but all branches of the federal government and relevant agencies must recognize the need to deschedule marijuana to protect the will of each state.”

Read more at Marijuana Moment

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
CannabisNewsPoliticsMarketsGeneralAnne MilgramDEAHHSPresident Biden
Beat the Market With Our Free Pre-Market Newsletter
Enter your email to get Benzinga's ultimate morning update: The PreMarket Activity Newsletter
Comments
Loading...